RIGVIR® is prescription medicine approved for the treatment of melanoma, local therapy of skin and subcutaneous metastases of melanoma, prevention of relapse and metastases after surgery. RIGVIR® is also an immunomodulator.

In clinical practice RIGVIR® is also used for other types of cancer, based on the individual judgment of the physician.



                                                SUMMARY OF PRODUCT CHARACTERISTICS